Screener
Vir Biotechnology, Inc. VIR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $80.08M+172% | -$125.7M-3.9% | -$42.92M+59.0% | -$163.14M+23.7% | -$110.96M+19.8% | ||
| $2.8M-3.9% | $2.81M-2.0% | $2.9M+0.4% | $3M+3.5% | $2.92M-31.5% | ||
| $12.39M-0.5% | $12.09M-14.0% | $11.21M-29.3% | $11.36M-32.0% | $12.45M-43.8% | ||
| —— | -$132.39M-69.5% | -$25.88M+70.5% | -$167.57M+2.3% | -$120.22M-54.4% | ||
| $32K-98.7% | $390K-76.1% | $348K-82.6% | $317K-88.5% | $2.54M+281% | ||
| -$197.14M-449% | $11.84M-90.7% | $86.65M-38.4% | $40.45M-65.9% | $56.46M-73.3% | ||
| $78.38M+3,731% | $162.52M+27,078% | $1.04M-17.7% | $102K+229% | $2.05M-30.5% | ||
| $4.56M+107% | $41.97M-14.9% | —— | -$127.02M— | -$61.72M-145% |
FAQ
- Where does Vir Biotechnology, Inc.'s cash flow data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
